Julien Fleurence
Julien Fleurence
Dirección de correo verificada de bcm.edu
Título
Citado por
Citado por
Año
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside
J Fleurence, D Cochonneau, S Fougeray, L Oliver, F Geraldo, M Terme, ...
Oncotarget 7 (27), 41172, 2016
222016
Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development
A Desselle, T Chaumette, MH Gaugler, D Cochonneau, J Fleurence, ...
PloS one 7 (11), e45423, 2012
172012
Glypican-3–Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma
SA Batra, P Rathi, L Guo, AN Courtney, J Fleurence, J Balzeau, RS Shaik, ...
Cancer Immunology Research 8 (3), 309-320, 2020
162020
Targeting O-acetyl-GD2 ganglioside for cancer immunotherapy
J Fleurence, S Fougeray, M Bahri, D Cochonneau, B Clémenceau, ...
Journal of immunology research 2017, 2017
102017
Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside
S Faraj, M Bahri, S Fougeray, A El Roz, J Fleurence, J Véziers, MD Leclair, ...
Oncoimmunology 7 (1), e1373232, 2018
82018
Impairing temozolomide resistance driven by glioma stem‐like cells with adjuvant immunotherapy targeting O‐acetyl GD2 ganglioside
J Fleurence, M Bahri, S Fougeray, S Faraj, S Vermeulen, E Pinault, ...
International Journal of Cancer 146 (2), 424-438, 2020
42020
O-acetylated gangliosides: Structure, biosynthesis, immunogenicity, functions and their potential for cancer immunotherapy
S Fougeray, J Fleurence, S Faraj, M Bahri, D Cochonneau, M Terme, ...
32016
Inhibition of tumor angiogenesis by globotriaosylceramide immunotargeting
S Birklé, A Desselle, T Chaumette, MH Gaugler, D Cochonneau, ...
Oncoimmunology 2 (4), e23700, 2013
22013
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
M Bahri, J Fleurence, S Faraj, MBM Daho, S Fougeray, S Birklé
JoVE (Journal of Visualized Experiments), e58291, 2019
12019
Glypican-3-Specific CAR NKT Cells Armored with IL-15 Mediate Potent Anti-Tumor Response Against Hepatocellular Carcinoma
R Shaik, P Rathi, N Schneller, T Nguyen, L Guo, A Courtney, J Fleurence, ...
MOLECULAR THERAPY 28 (4), 34-35, 2020
2020
A Phase 1 Clinical Trial Using Armored GPC3-Car T Cells for Children with Relapsed/Refractory Liver Tumors
DHM Steffin, N Ghatwai, S Batra, JJ Fleurence, P Rathi, AN Courtney, ...
MOLECULAR THERAPY 28 (4), 212-213, 2020
2020
Use of antibody against o-acetylated gd2 ganglioside to improve the therapeutic potential of drugs
S Birkle, J Fleurence, S Faraj, JM Le Doussal, D Cochonneau, M Terme, ...
US Patent App. 16/466,769, 2019
2019
Ciblage du GD2-O-acétylé par un anticorps monoclonal dans le glioblastome multiforme
J Fleurence
Nantes, 2017
2017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–13